Jul 24 2015
The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences (ACPHS) will host a Symposium and Workshop August 3-7 to explore the latest advances in the field of Nanomedicine. The event will take place in the Gozzo Student Center located on the ACPHS Campus.
Nanomedicine is a rapidly developing field of biomedical research that has already demonstrated great potential for improving drug and gene delivery. Next generation nano-therapies have been shown to precisely deliver drugs and recombinant DNAs to target areas of disease or tumors, maximizing clinical benefits while limiting side effects. Such approaches may also improve early diagnoses through bio-imaging techniques, biomarkers, and biosensors.
"Advances in Nanomedicine are happening so quickly that it can be difficult to stay current with the latest developments. The goal of our symposium and accompanying workshop is to update participants on the state of Nanomedicine today courtesy of some of the brightest minds in the field," said Shaker Mousa, Executive Director of the Pharmaceutical Research Institute and Vice Provost of Research at ACPHS. "The Capital Region's strengths in nanotechnology, biomedical research, higher education, and health care make Albany an ideal location for such an event."
The Symposium will gather speakers and experts from a range of academic, corporate, and government entities including the following:
- Local Institutions - Albany College of Pharmacy and Health Sciences, Albany Medical Center, Rensselaer Polytechnic Institute, SUNY Polytechnic Institute, University at Albany
- Regional Universities - Cornell University, Northeastern University, Rutgers University, SUNY Buffalo, Syracuse University, University of Massachusetts (Amherst)
- Corporations - Bristol Myers-Squibb, Microfluidics, Particle Sciences
- Government - National Cancer Institute, U.S. Consumer Product Safety Commission
"Nanomedicine holds great promise for the next generation of drug therapy. It has the potential of combining high selectivity with low toxicity to greatly improve drug efficacy," said Greg Dewey, Ph.D., president of Albany College of Pharmacy and Health Sciences. "ACPHS is very pleased to be hosting this forward-looking conference of researchers and will continue to actively advance this emerging field."
Individuals who will benefit from attending include those working and/or studying in the fields of biological and physical sciences, biomedical and biomaterials engineering, pharmacy, biotech/pharmaceutical industry, medicine, and other healthcare-related professions.
Source: http://www.acphs.edu/